74 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
7:01am
website, www.kiorapharma.com, and social media accounts that could be relevant to investors. We encourage investors to follow us on Twitter and LinkedIn
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
25 Mar 24
Results of Operations and Financial Condition
7:03am
. In addition to news releases and SEC filings, we expect to post information on our website, www.kiorapharma.com, and social media accounts that could
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
to general health & vision, ocular pain, near & distance activities, social functioning, mental health, dependency, driving, color vision
8-K
EX-99.1
vaulki3q5pet1n9j85
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-99.1
grdlbvspglz 09
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
vuiwmd9w4
9 Nov 23
Regulation FD Disclosure
7:02am
8-K
EX-99.1
t8imv
9 Nov 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
1ra8ooemfpsqdfuy
6 Nov 23
Topline Phase I/II First-in-Human Results Presented at AAO 2023
6:05am
8-K
EX-99.1
sukg l0bhrgfj39slas
21 Sep 23
Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
7:00am
DEFA14A
EX-99.1
mzeu veeafztoca
1 Sep 23
Additional proxy soliciting materials
7:00am
8-K
EX-99.1
23b1p
1 Sep 23
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
7:00am
8-K
EX-99.1
przxh
8 Aug 23
Kiora Pharmaceuticals Announces Q2 2023 Earnings and Business Update, Highlighting Pipeline Updates and Clinical Development Progress
7:14am
8-K
EX-99.1
snx9olpn3
1 Aug 23
Biotech Leader Carmine Stengone Joins Kiora Pharmaceuticals' Board of Directors
7:00am
8-K
EX-99.1
u2vczim3 r3q3t
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
8-K
EX-99.1
e90v85q8
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
8-K
EX-99.2
m0laj8k
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm